Thiazolidinedione Use and the Risk of Fractures

CMAJ - Canada
doi 10.1503/cmaj.1090005
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Thiazolidinedione Use and Atrial Fibrillation in Diabetic Patients: A Meta-Analysis

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2017English

Dietary Patterns and Fractures Risk in the Elderly

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures

Journal of Preventive Medicine and Public Health
MedicineEnvironmentalPublic HealthOccupational Health
2018English

Long-Term Use of Fluoxetine and Multiple Skeleton Fractures

European Journal of Clinical Pharmacology
MedicinePharmacology
2010English

Lactation, Bone Strength and Reduced Risk of Bone Fractures

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2012English

Bone Disease After Transplantation: Osteoporosis and Fractures Risk

Arquivos Brasileiros de Endocrinologia & Metabologia
2014English

Adipose Tissue Distribution and Risk of Metabolic Disease: Does Thiazolidinedione-Induced Adipose Tissue Redistribution Provide a Clue to the Answer?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2007English

Thiazolidinedione Use Is Associated With Better Survival in Hemodialysis Patients With Non-Insulin Dependent Diabetes

Kidney International
Nephrology
2009English

Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy